Stable patients who stop taking beta-blockers a year or more after a heart attack fare no worse than those who keep taking ...

For stabilized AMI without left ventricular systolic dysfunction or HF, discontinuing β-blockers after 1 year or longer is noninferior to continuing it.

Heart failure sounds alarming—and rightfully so. Yet approximately 6.5 million Americans currently live with this condition, many with the specific variant called systolic heart failure, and a ...

The SMART-DECISION trial has found that in stabilized patients after myocardial infarction (MI) without heart failure or left ventricular systolic dysfunction, discontinuing beta-blockers after one ...

Living with a heart that struggles to pump effectively creates daily challenges for millions of Americans. Systolic heart failure fundamentally changes how patients experience everyday activities.

Patients hospitalized for severe COVID-19 exhibit cardiac systolic dysfunction and small vessel disease at long-term follow-up. This is according to a new study from Karolinska Institutet and ...

Through a deep-learning model, researchers have shown that ordinary ECG images can be leveraged to identify patients with an LV ejection fraction below 40%. Their approach also appears able to ...

LBBB is linked to electrical abnormalities, causing inefficient heart pumping, dilation, and systolic dysfunction. The study found LBBB associated with increased heart failure risk, surpassing other ...

Chicago, IL - Prolongation of the QRS interval, an electrocardiographic marker for ventricular dyssynchrony, is present in more than a third of low-LVEF patients hospitalized for acute heart failure ...

The role of long-term beta-blocker therapy after a myocardial infarction in patients without left ventricular systolic dysfunction or heart failure is unclear in the era of contemporary ...